Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a higher dose of adenosine sharpen heart scans?

NCT ID NCT06578234

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial is testing whether a higher dose of adenosine, a drug used during cardiac MRI to stress the heart, improves blood flow imaging compared to the standard dose. The study includes 180 adults with suspected or known coronary artery disease or heart failure. By comparing the two doses, researchers hope to reduce false results and improve diagnosis and treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Adenosine
What this could lead to
If high-dose adenosine works better, it could improve the accuracy of cardiac MRI stress tests, leading to better diagnosis and treatment decisions for people with coronary artery disease.
What could go wrong
This is a phase 4 trial, but it's still testing a dose difference that may not show a clear benefit. High-dose adenosine may cause more side effects like chest discomfort or shortness of breath.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients: 1. The subject has given their written consent to participate in the trial. 2. Are referred to Department of Clinical Physiology, Skåne University Hospital, for suspected or known CCS or heart failure 3. Matches the inclusion criteria for sex and age (6 females and 6 males from each group in each age decade from 40 to \>80 years old) 4. Matches the inclusion criteria for no known heart failure (group b) or known heart failure (group c) 5. No caffein intake \<24h prior to the examination Healthy volunteers: 1. The subject has given their written consent to participate in the trial. 2. Matches the inclusion criteria for sex and age (6 females and 6 males from each group in each age decade from 40 to \>80 years old) 3. No caffein intake \<24h prior to the examination Exclusion Criteria: Patients: 1. Acute referral (in-house patients) 2. Clinically unstable 3. Acute chest pain 4. Severe or decompensated heart failure 5. Non sinus rhythm (e.g. atrial fibrillation) 6. Asthma or severe chronic obstructive pulmonary disease 7. Known chronic renal failure (eGFR \<45mL/min/1.73m2) 8. AV-block II or III 9. Left Bundle Branch Block 10. Systolic blood pressure \<90 mmHg or \>230 mmHg at rest 11. Increased intracranial pressure 12. Known allergy or adverse reaction to adenosine or mannitol 13. Known allergy or adverse reaction to gadolinium contrast agents 14. Treatment with medication containing dipyradimol or teofyllamin/teofyllin 15. Claustrophobia 16. Devices contraindicated to CMR imaging (pacemaker, implants, intracranial clips etc) 17. Pregnancy or breast feeding (screened by question only) 18. Inability to give informed consent due to mental state, language difficulties etc Healthy volunteers: 1. Any of the exclusion criteria for patients 2. Blood pressure \> 140/90 measured according to clinical routine 3. Known systemic disease 4. Known cardiac disease 5. Cardiovascular medication 6. Medication that might influence cardiovascular health 7. Smoking

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic coronary syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital

    RECRUITING

    Lund, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.